Newsroom | 210658 results

Sorted by: Latest

Health
-

Inszone Insurance Services Expands Benefits Department in Michigan with Acquisition of Voyage Benefits, LLC

SACRAMENTO, Calif.--(BUSINESS WIRE)--Inszone Insurance Services, a rapidly growing national provider of commercial, personal, and benefits insurance, is pleased to announce the acquisition of Voyage Benefits, LLC, a respected health and life insurance agency based in Grand Rapids, Michigan. Founded and led by Principal and Licensed Agent Kelly Syren, Voyage Benefits has built a reputation for providing personalized and comprehensive health insurance and Medicare solutions to individuals and fam...
-

La FDA autorise la première lentille de contact à profondeur de champ étendue pour la presbytie

BOCA RATON, Floride--(BUSINESS WIRE)--Cataltheia Group et sa filiale américaine Bruno Vision Care LLC, leader dans le domaine de l’innovation en matière de santé oculaire, ont annoncé aujourd’hui que la Food and Drug Administration (FDA) américaine avait autorisé la première et unique lentille de contact souple (hydrophile) jetable à usage quotidien pour la presbytie utilisant la technologie optique brevetée Extended Depth of Focus (EDOF), permettant ainsi sa commercialisation aux États-Unis. D...
-

L'FDA approva le prime lenti a contatto con profondità di focalizzazione estesa per la presbiopia

BOCA RATON, Fla.--(BUSINESS WIRE)--The Cataltheia Group e la sua controllata, Bruno Vision Care LLC, azienda leader nell'innovazione della salute degli occhi, oggi ha annunciato che la Food and Drug Administration (FDA) statunitense ha approvato la prima e unica Daily Disposable Soft (Hydrophilic) Contact Lens per la presbiopia che utilizza la tecnologia brevettata di progettazione ottica Extended Depth of Focus (EDOF), dando il via alla distribuzione commerciale negli Stati Uniti. Deseyne® off...
-

La FDA autoriza la primera lente de contacto con profundidad de foco extendida para la presbicia

BOCA RATÓN, Florida--(BUSINESS WIRE)--Cataltheia Group y su filial en los Estados Unidos, Bruno Vision Care LLC, líder en innovación en salud ocular, anunciaron hoy que la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA) ha autorizado la primera y única lente de contacto blanda (hidrofílica) diaria y desechable para la presbicia que utiliza una tecnología óptica patentada de profundidad de foco extendida (EDOF, por sus siglas en inglés), cuya distribución comercial ahora s...
-

FDA keurt eerste Extended Depth of Focus-contactlens voor presbyopie goed

BOCA RATON, Fla.--(BUSINESS WIRE)--De Cataltheia Group en Bruno Vision Care LLC, de Amerikaanse dochteronderneming van het bedrijf en leider op gebied van innovatie voor de gezondheid van de ogen, maakten vandaag bekend dat de Amerikaanse FDA (U.S. Food & Drug Administration) de eerste en enige Daily Disposable Soft (hydrofiele) contactlens voor presbyopie heeft goedgekeurd, een contactlens die gebruik maakt van de gepatenteerde EDOF (Extended Depth of Focus) optische ontwerptechnologie. Da...
-

FDA genehmigt erste Kontaktlinse mit erweiterter Tiefenschärfe für Presbyopie

BOCA RATON, Fla.--(BUSINESS WIRE)--Die Cataltheia Group und ihre US-Tochtergesellschaft Bruno Vision Care LLC, ein führendes Unternehmen im Bereich der Augenheilkunde, gaben heute bekannt, dass die US-amerikanische Arzneimittelbehörde FDA (Food and Drug Administration) die erste und einzige weiche (hydrophile) Einweg-Tageskontaktlinse für Presbyopie zugelassen hat, die die patentierte optische EDOF-Technologie (Extended Depth of Focus) nutzt und damit den kommerziellen Vertrieb in den Vereinigt...
-

Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study

SAN DIEGO--(BUSINESS WIRE)--Janux provided a program update on its Phase 1 study of JANX008, an EGFR-targeted TRACTr, following Phase 1a completion and cohort expansion....
-

Henry Schein Provides Update on CEO Search Process

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) (the “Company”), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that it expects to appoint the Company’s next CEO by mid-January 2026. Philip A. Laskawy, Lead Director for Henry Schein said, “We are pleased with the progress we have made in our search for Henry Schein’s next CEO. The search process is nearing completion but will not be finalized before year...
-

Akumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care

PLANTATION, Fla.--(BUSINESS WIRE)--Akumin Inc. (together with its subsidiaries “Akumin” or the “Company”) announced today that it entered into an agreement (the “Support Agreement”) with certain noteholders representing over 95% of outstanding senior secured notes due in 2027 and 2028 (together, the “Senior Secured Notes”), and Stonepeak, a leading alternative investment firm, that will reduce debt, enhance liquidity and extend its debt maturities related to the Senior Secured Notes. Under the...
-

New Outpatient Infusion Center Opening in Marietta, GA Expands the National Presence of Advanced Infusion Care

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce the opening of another Advanced Infusion Care Center (AICC). This latest one is in Marietta, GA represents a significant step forward in AIC’s ongoing expansion and its commitment to increasing access to compassionate, high-quality infusion services across the country. The opening of more and more AICC sites highlights AIC’s strategi...